# Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into Patients With Multiple Sclerosis

> **NCT01453764** · NA · WITHDRAWN · sponsor: **Ageless Regenerative Institute**

## Conditions studied

- Multiple Sclerosis
- Autoimmune Diseases
- Autoimmune Diseases of the Nervous System
- Nervous System Diseases

## Interventions

- **PROCEDURE:** Harvesting and Implantation of SVF

## Key facts

- **NCT ID:** NCT01453764
- **Lead sponsor:** Ageless Regenerative Institute
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-04
- **Primary completion:** 2018-12
- **Final completion:** 2019-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** company dissolved
- **Last updated:** 2017-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01453764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01453764, "Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into Patients With Multiple Sclerosis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01453764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*